Ignite Creation Date:
2025-12-26 @ 11:48 AM
Ignite Modification Date:
2026-01-24 @ 11:11 PM
Study NCT ID:
NCT05223816
Status:
RECRUITING
Last Update Posted:
2024-08-09
First Post:
2021-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Sponsor:
Virogin Biotech Canada Ltd
Organization: